COMMUNITY-ACQUIRED PNEUMONIA
Clinical trials for COMMUNITY-ACQUIRED PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new COMMUNITY-ACQUIRED PNEUMONIA trials appear
Sign up with your email to follow new studies for COMMUNITY-ACQUIRED PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to keep viral pneumonia patients out of hospital
Disease control TerminatedThis Phase 2 trial tested the drug silmitasertib (CX-4945) plus standard care in adults with pneumonia caused by COVID-19 or influenza. The goal was to see if the drug could reduce the need for hospitalization or prevent death. The study planned to enroll 120 people but was termi…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA
Phase: PHASE2 • Sponsor: Senhwa Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Scientists probe immune cells in pneumonia to unlock ARDS secrets
Knowledge-focused TerminatedThis study looked at how certain immune cells, called non-conventional T cells, behave in patients with severe pneumonia and acute respiratory distress syndrome (ARDS). Researchers collected blood and airway samples from 258 intensive care unit patients to track these cells over …
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA
Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC